HOLX
$75.41+0.08 (+0.11%)
Hologic, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnosti...
Recent News
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening
HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.
Is Hologic Stock Outperforming the Dow?
Although Hologic has exceeded the Dow over the past year, analysts remain cautious about the stock’s prospects.
Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?
Hologic nears its $76 buyout price as Diagnostics faces headwinds, tariffs hurt, and the stock trades at a sector premium.
How The Hologic (HOLX) Story Is Shifting Toward A Deal Driven Wait And See Trade
Hologic’s latest update keeps its fair value estimate steady at about US$76.60 per share, signaling no change to the headline price target in current analyst models. That stability comes as research shifts the stock toward a wait and see idea, with the pending buyout of up to US$79 per share now setting the tone for how many analysts frame upside and risk. As you read on, you will see how to track this evolving, deal-driven narrative and what it could mean for your own view on...